Previous Article | Next Article 
Journal of Virology, June 2000, p. 5142-5150, Vol. 74, No. 11
0022-538X/00/$04.00+0
Relationship between Human Immunodeficiency Virus
Type 1 Gag Multimerization and Membrane Binding
Akira
Ono,
Dimiter
Demirov, and
Eric O.
Freed*
Laboratory of Molecular Microbiology,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20892-0460
Received 23 December 1999/Accepted 10 March 2000
The human immunodeficiency virus type 1 (HIV-1) Gag precursor,
Pr55Gag, is necessary and sufficient for the assembly and
release of viruslike particles. Binding of Gag to membrane and Gag
multimerization are both essential steps in virus assembly, yet the
domains responsible for these events have not been fully defined. In
addition, the relationship between membrane binding and Gag-Gag
interaction remains to be elucidated. To investigate these issues, we
analyzed, in vivo, the membrane-binding and assembly properties of a
series of C-terminally truncated Gag mutants. Pr55Gag was
truncated at the C terminus of matrix (MAstop), between the N- and
C-terminal domains of capsid (CA146stop), at the C terminus of capsid
(p41stop), at the C terminus of p2 (p43stop), and after the N-terminal
35 amino acids of nucleocapsid (NC35stop). The ability of these
truncated Gag molecules to assemble and release viruslike particles and
their capacity to copackage into particles when coexpressed with
full-length Gag were determined. We demonstrate that the amount of
truncated Gag incorporated into particles is incrementally increased by
extension from CA146 to NC35, suggesting that multiple sites in this
region are involved in Gag multimerization. Using membrane flotation
centrifugation, we observe that MA shows significantly reduced membrane
binding relative to full-length Gag but that CA146 displays
steady-state membrane-binding properties comparable to those of
Pr55Gag. The finding that the CA146 mutant, which contains
only matrix and the N-terminal domain of capsid, exhibits levels of
steady-state membrane binding equivalent to those of full-length Gag
indicates that strong Gag-Gag interaction domains are not required for
the efficient binding of HIV-1 Gag to membrane.
*
Corresponding author. Mailing address: Bldg. 4, Rm.
307, NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892-0460. Phone: (301) 402-3215. Fax: (301) 402-0226. E-mail: EFreed{at}nih.gov.
Journal of Virology, June 2000, p. 5142-5150, Vol. 74, No. 11
0022-538X/00/$04.00+0
This article has been cited by other articles:
-
Ott, D. E., Coren, L. V., Shatzer, T.
(2009). The Nucleocapsid Region of Human Immunodeficiency Virus Type 1 Gag Assists in the Coordination of Assembly and Gag Processing: Role for RNA-Gag Binding in the Early Stages of Assembly. J. Virol.
83: 7718-7727
[Abstract]
[Full Text]
-
Hogue, I. B., Hoppe, A., Ono, A.
(2009). Quantitative Fluorescence Resonance Energy Transfer Microscopy Analysis of the Human Immunodeficiency Virus Type 1 Gag-Gag Interaction: Relative Contributions of the CA and NC Domains and Membrane Binding. J. Virol.
83: 7322-7336
[Abstract]
[Full Text]
-
Joshi, A., Ablan, S. D., Soheilian, F., Nagashima, K., Freed, E. O.
(2009). Evidence that Productive Human Immunodeficiency Virus Type 1 Assembly Can Occur in an Intracellular Compartment. J. Virol.
83: 5375-5387
[Abstract]
[Full Text]
-
Waheed, A. A., Ablan, S. D., Soheilian, F., Nagashima, K., Ono, A., Schaffner, C. P., Freed, E. O.
(2008). Inhibition of Human Immunodeficiency Virus Type 1 Assembly and Release by the Cholesterol-Binding Compound Amphotericin B Methyl Ester: Evidence for Vpu Dependence. J. Virol.
82: 9776-9781
[Abstract]
[Full Text]
-
Kawada, S., Goto, T., Haraguchi, H., Ono, A., Morikawa, Y.
(2008). Dominant Negative Inhibition of Human Immunodeficiency Virus Particle Production by the Nonmyristoylated Form of Gag. J. Virol.
82: 4384-4399
[Abstract]
[Full Text]
-
Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W.-S., Ono, A.
(2008). Interaction between the Human Immunodeficiency Virus Type 1 Gag Matrix Domain and Phosphatidylinositol-(4,5)-Bisphosphate Is Essential for Efficient Gag Membrane Binding. J. Virol.
82: 2405-2417
[Abstract]
[Full Text]
-
Kenney, S. P., Lochmann, T. L., Schmid, C. L., Parent, L. J.
(2008). Intermolecular Interactions between Retroviral Gag Proteins in the Nucleus. J. Virol.
82: 683-691
[Abstract]
[Full Text]
-
Jager, S., Gottwein, E., Krausslich, H.-G.
(2007). Ubiquitination of Human Immunodeficiency Virus Type 1 Gag Is Highly Dependent on Gag Membrane Association. J. Virol.
81: 9193-9201
[Abstract]
[Full Text]
-
Dalton, A. K., Ako-Adjei, D., Murray, P. S., Murray, D., Vogt, V. M.
(2007). Electrostatic Interactions Drive Membrane Association of the Human Immunodeficiency Virus Type 1 Gag MA Domain. J. Virol.
81: 6434-6445
[Abstract]
[Full Text]
-
Gomez, C. Y., Hope, T. J.
(2006). Mobility of Human Immunodeficiency Virus Type 1 Pr55Gag in Living Cells.. J. Virol.
80: 8796-8806
[Abstract]
[Full Text]
-
Joshi, A., Nagashima, K., Freed, E. O.
(2006). Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.. J. Virol.
80: 7939-7951
[Abstract]
[Full Text]
-
Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., Summers, M. F.
(2006). From the Cover: Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. USA
103: 11364-11369
[Abstract]
[Full Text]
-
Ryzhova, E. V., Vos, R. M., Albright, A. V., Harrist, A. V., Harvey, T., Gonzalez-Scarano, F.
(2006). Annexin 2: a Novel Human Immunodeficiency Virus Type 1 Gag Binding Protein Involved in Replication in Monocyte-Derived Macrophages. J. Virol.
80: 2694-2704
[Abstract]
[Full Text]
-
Ono, A., Waheed, A. A., Joshi, A., Freed, E. O.
(2005). Association of Human Immunodeficiency Virus Type 1 Gag with Membrane Does Not Require Highly Basic Sequences in the Nucleocapsid: Use of a Novel Gag Multimerization Assay. J. Virol.
79: 14131-14140
[Abstract]
[Full Text]
-
Dalton, A. K., Murray, P. S., Murray, D., Vogt, V. M.
(2005). Biochemical Characterization of Rous Sarcoma Virus MA Protein Interaction with Membranes. J. Virol.
79: 6227-6238
[Abstract]
[Full Text]
-
Zhou, Y., Zhang, H., Siliciano, J. D., Siliciano, R. F.
(2005). Kinetics of Human Immunodeficiency Virus Type 1 Decay following Entry into Resting CD4+ T Cells. J. Virol.
79: 2199-2210
[Abstract]
[Full Text]
-
Wong, S. B. J., Siliciano, R. F.
(2005). Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice. J. Virol.
79: 1701-1712
[Abstract]
[Full Text]
-
Melamed, D., Mark-Danieli, M., Kenan-Eichler, M., Kraus, O., Castiel, A., Laham, N., Pupko, T., Glaser, F., Ben-Tal, N., Bacharach, E.
(2004). The Conserved Carboxy Terminus of the Capsid Domain of Human Immunodeficiency Virus Type 1 Gag Protein Is Important for Virion Assembly and Release. J. Virol.
78: 9675-9688
[Abstract]
[Full Text]
-
Perez-Caballero, D., Hatziioannou, T., Martin-Serrano, J., Bieniasz, P. D.
(2004). Human Immunodeficiency Virus Type 1 Matrix Inhibits and Confers Cooperativity on Gag Precursor-Membrane Interactions. J. Virol.
78: 9560-9563
[Abstract]
[Full Text]
-
Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W.-S., Pathak, V. K.
(2004). Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs. J. Biol. Chem.
279: 35822-35828
[Abstract]
[Full Text]
-
Costa, L. J., Zheng, Y.-H., Sabotic, J., Mak, J., Fackler, O. T., Peterlin, B. M.
(2004). Nef Binds p6* in GagPol during Replication of Human Immunodeficiency Virus Type 1. J. Virol.
78: 5311-5323
[Abstract]
[Full Text]
-
Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D., Summers, M. F.
(2004). From the Cover: Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. USA
101: 517-522
[Abstract]
[Full Text]
-
Feng, X., Vander Heyden, N., Ratner, L.
(2003). Alpha Interferon Inhibits Human T-Cell Leukemia Virus Type 1 Assembly by Preventing Gag Interaction with Rafts. J. Virol.
77: 13389-13395
[Abstract]
[Full Text]
-
von Schwedler, U. K., Stray, K. M., Garrus, J. E., Sundquist, W. I.
(2003). Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein. J. Virol.
77: 5439-5450
[Abstract]
[Full Text]
-
Liang, C., Hu, J., Whitney, J. B., Kleiman, L., Wainberg, M. A.
(2003). A Structurally Disordered Region at the C Terminus of Capsid Plays Essential Roles in Multimerization and Membrane Binding of the Gag Protein of Human Immunodeficiency Virus Type 1. J. Virol.
77: 1772-1783
[Abstract]
[Full Text]
-
Le Blanc, I., Blot, V., Bouchaert, I., Salamero, J., Goud, B., Rosenberg, A. R., Dokhelar, M.-C.
(2002). Intracellular Distribution of Human T-Cell Leukemia Virus Type 1 Gag Proteins Is Independent of Interaction with Intracellular Membranes. J. Virol.
76: 905-911
[Abstract]
[Full Text]
-
Ono, A., Freed, E. O.
(2001). Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA
98: 13925-13930
[Abstract]
[Full Text]
-
Lindwasser, O. W., Resh, M. D.
(2001). Multimerization of Human Immunodeficiency Virus Type 1 Gag Promotes Its Localization to Barges, Raft-Like Membrane Microdomains. J. Virol.
75: 7913-7924
[Abstract]
[Full Text]
-
Eastman, S. W., Linial, M. L.
(2001). Identification of a Conserved Residue of Foamy Virus Gag Required for Intracellular Capsid Assembly. J. Virol.
75: 6857-6864
[Abstract]
[Full Text]
-
Tritel, M., Resh, M. D.
(2001). The Late Stage of Human Immunodeficiency Virus Type 1 Assembly Is an Energy-Dependent Process. J. Virol.
75: 5473-5481
[Abstract]
[Full Text]
-
Rayne, F., Bouamr, F., Lalanne, J., Mamoun, R. Z.
(2001). The NH2-Terminal Domain of the Human T-Cell Leukemia Virus Type 1 Capsid Protein Is Involved in Particle Formation. J. Virol.
75: 5277-5287
[Abstract]
[Full Text]